Sign in
4

Changes in Ownership

NewAmsterdam Pharma Co N.V. Filed Acc 0001193125-26-099073

Chief Scientific Officer sold 300,000 shares at an average $30.30 ($9,090,868)

  • Chief Scientific Officer acquired 300,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kastelein Johannes Jacob Pieter · Chief Scientific Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-05 Exercise or conversion : show line 1 in the form 10b5-1 +104,467 173,769 I
2026-03-05 Sale : show line 2 in the form 10b5-1 −104,467 $30.30 $3,165,350 69,302 I
2026-03-06 Exercise or conversion : show line 3 in the form 10b5-1 +94,124 163,426 I
2026-03-06 Sale : show line 4 in the form 10b5-1 −94,124 $30.32 $2,853,840 69,302 I
2026-03-09 Exercise or conversion : show line 5 in the form 10b5-1 +101,409 170,711 I
2026-03-09 Sale : show line 6 in the form 10b5-1 −101,409 $30.29 $3,071,679 69,302 I
Open-market sales · 300,000 sh · avg $30.30 · $9,090,868

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-03-05 Exercise or conversion : show line 7 in the form 10b5-1 Option (right to buy) −104,467 715,762 I
2026-03-06 Exercise or conversion : show line 8 in the form 10b5-1 Option (right to buy) −94,124 621,638 I
2026-03-09 Exercise or conversion : show line 9 in the form 10b5-1 Option (right to buy) −101,409 520,229 I
Loading xslF345X05/ownership.xml…